HomeInsightsStock Comparison

Acutaas Chemicals Ltd vs Bal Pharma Ltd Stock Comparison

Acutaas Chemicals Ltd vs Bal Pharma Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Ami Organics Ltd is ₹ 1104 as of 13 Jun 15:30.
  • The P/E Ratio of Ami Organics Ltd changed from 50.6 on March 2022 to 94.3 on March 2024 . This represents a CAGR of 23.06% over 3 yearsThe P/E Ratio of Bal Pharma Ltd changed from 16.8 on March 2021 to 19.5 on March 2024 . This represents a CAGR of 3.80% over 4 years.
  • The Market Cap of Ami Organics Ltd changed from ₹ 3642 crore on March 2022 to ₹ 4036 crore on March 2024 . This represents a CAGR of 3.48% over 3 yearsThe Market Cap of Bal Pharma Ltd changed from ₹ 46.13 crore on March 2020 to ₹ 144.21 crore on March 2024 . This represents a CAGR of 25.60% over 5 years.
  • The revenue of Ami Organics Ltd for the Mar '25 is ₹ 314.26 crore as compare to the Dec '24 revenue of ₹ 276.66 crore. This represent the growth of 13.59% The revenue of Bal Pharma Ltd for the Mar '25 is ₹ 82.96 crore as compare to the Dec '24 revenue of ₹ 73.66 crore. This represent the growth of 12.63%.
  • The ebitda of Ami Organics Ltd for the Mar '25 is ₹ 90.74 crore as compare to the Dec '24 ebitda of ₹ 70.34 crore. This represent the growth of 29% The ebitda of Bal Pharma Ltd for the Mar '25 is ₹ 8.72 crore as compare to the Dec '24 ebitda of ₹ 8.26 crore. This represent the growth of 5.57%.
  • The net profit of Ami Organics Ltd changed from ₹ 22.24 crore to ₹ 62.72 crore over 8 quarters. This represents a CAGR of 67.93% The net profit of Bal Pharma Ltd changed from ₹ 0.09 crore to ₹ 5.42 crore over 8 quarters. This represents a CAGR of 676.03% .
  • The Dividend Payout of Ami Organics Ltd changed from 15.19 % on March 2022 to 25.33 % on March 2024 . This represents a CAGR of 18.58% over 3 yearsThe Dividend Payout of Bal Pharma Ltd changed from 16.29 % on March 2021 to 18.46 % on March 2024 . This represents a CAGR of 3.18% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ami Organics Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

About Bal Pharma Ltd

  • Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87.
  • In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
  • The company promotes its products through the common sales force of the group but proposes to induct its own soon.
  • It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited.

Ami Organics Ltd News Hub

News

Board of AMI Organics recommends final dividend

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2...

Read more

02 May 2025 14:08

News

Ami Organics jumps after Q4 PAT soars to Rs 627 cr

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter e...

Read more

02 May 2025 14:49

News

AMI Organics to hold board meeting

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025. P...

Read more

25 Apr 2025 11:18

News

Ami Organics' Unit II receives Japan PMDA nod for GMP compliance

Ami Organics' manufacturing facility, Unit II situated at Ankleshwar, which is involved in...

Read more

24 Apr 2025 15:57

News

AMI Organics to hold EGM

AMI Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

16 Apr 2025 20:44

News

Board of Ami Organics approves change in company name to Acutaas Chemicals

The Board of Ami Organics at its meeting held on 16 April 2025 has approved the change in ...

Read more

16 Apr 2025 15:03

Bal Pharma Ltd News Hub

News

Board of Bal Pharma recommends final dividend

Bal Pharma announced that the Board of Directors of the Company at its meeting held on 29 ...

Read more

30 May 2025 11:20

News

Bal Pharma to declare Quarterly Results

Bal Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2025. Po...

Read more

17 May 2025 11:42

News

Bal Pharma Ltd leads gainers in 'B' group

Chemcrux Enterprises Ltd, Maral Overseas Ltd, Growington Ventures India Ltd and Orchasp Lt...

Read more

03 Apr 2025 12:15

News

Bal Pharma to hold board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 13 February 202...

Read more

25 Jan 2025 10:17

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 202...

Read more

06 Nov 2024 20:13

News

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 202...

Read more

31 Aug 2024 10:27

SWOT Analysis Of Bal Pharma Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Ami Organics Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Ami Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ami Organics Ltd and Bal Pharma Ltd

Which company has a larger market capitalization, Ami Organics Ltd or Bal Pharma Ltd?

Market cap of Ami Organics Ltd is 9,039 Cr while Market cap of Bal Pharma Ltd is 164 Cr

What are the key factors driving the stock performance of Ami Organics Ltd and Bal Pharma Ltd?

The stock performance of Ami Organics Ltd and Bal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ami Organics Ltd and Bal Pharma Ltd?

As of June 14, 2025, the Ami Organics Ltd stock price is INR ₹1104.15. On the other hand, Bal Pharma Ltd stock price is INR ₹103.33.

How do dividend payouts of Ami Organics Ltd and Bal Pharma Ltd compare?

To compare the dividend payouts of Ami Organics Ltd and Bal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions